ArticleEuropean journal of nuclear medicine and molecular imaging2026

Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy.

Song Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.